Ono Announces Completion of Cancellation of Treasury Stock
(Cancellation of treasury stock pursuant to the provisions of Article 178 of the Companies Act)
Osaka, Japan, April 28, 2022 - Ono Pharmaceutical Co., Ltd. (President and CEO, Gyo Sagara; “the Company”) today announced that, as resolved by the Board of Director’s meeting held on April 6, 2022, it completed cancellation of treasury stock pursuant to the provisions of Article 178 of the Companies Act on April 28, 2022.
|1.||Class of shares cancelled||： Common stock of the Company|
|2.||Total number of shares cancelled||： 10,916,200 shares
(2.07% of total issued shares prior to cancellation)
|3.||Date of cancellation||： April 28, 2022|
|Total number of issued shares (after cancellation)||：517,425,200 shares|